Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2009 September;61(3) > Minerva Urologica e Nefrologica 2009 September;61(3):291-300

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

  THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA


Minerva Urologica e Nefrologica 2009 September;61(3):291-300

language: English

Transurethral resection of the prostate: defending its leading position in the management of benign prostatic enlargement

Wendt-Nordahl G. 1, Cao Y. 2, Häcker A. 3, Michel M. S. 3, Knoll T. 1

1 Department of Urology, Hospital Sindelfingen-Böblingen, Germany
2 Department of Urology, Qingdao University Affiliated Hospital, P. R. China
3 Department of Urology, University Medicine Mannheim, Germany


PDF  


Although challenged by medical therapy and numerous minimal-invasive treatment modalities, transurethral resection of the prostate (TURP) is still considered as the gold standard of interventional treatment of benign prostatic enlargement (BPE). It is characterized by an immediate improvement in symptoms and voiding parameters and achieves long lasting results. While its efficacy is out of question, the associated peri- and postoperative morbidity remains a major point of criticism and has let to the introduction of numerous less invasive treatment options. On the other hand, this also brought various improvements in the technique of TURP aiming to improve treatment results and reduce perioperative morbidity. This review article gives an overview over the historical development, treatment results, associated complications and recent technical developments in TURP, highlighting especially the role of bipolar TURP.

top of page

Publication History

Cite this article as

Corresponding author e-mail